Stuttgart - Delayed Quote EUR
Bicycle Therapeutics PLC (50BA.SG)
As of 8:03 AM GMT+1. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-202,616.00
-60,628.00
-86,111.00
-14,794.00
-17,789.00
Investing Cash Flow
-918.00
-2,929.00
-18,987.00
-2,030.00
-1,200.00
Financing Cash Flow
519,933.00
250,027.00
6,692.00
320,725.00
62,843.00
End Cash Position
889,033.00
526,970.00
339,154.00
438,680.00
135,990.00
Income Tax Paid Supplemental Data
690.00
562.00
2,228.00
73.00
124.00
Interest Paid Supplemental Data
2,067.00
2,753.00
2,793.00
2,515.00
378.00
Capital Expenditure
-918.00
-2,929.00
-18,987.00
-2,030.00
-1,200.00
Issuance of Capital Stock
544,137.00
249,345.00
5,703.00
298,542.00
48,144.00
Issuance of Debt
--
--
--
15,000.00
15,000.00
Free Cash Flow
-203,534.00
-63,557.00
-105,098.00
-16,824.00
-18,989.00
12/31/2020 - 5/27/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
698.F Achilles Therapeutics plc
0.9350
0.00%
MSCLF Satellos Bioscience Inc.
0.6320
+0.32%
BRNS Barinthus Biotherapeutics plc
1.4715
-1.24%
CU6.AX Clarity Pharmaceuticals Ltd
7.20
+2.71%
OXB.L Oxford Biomedica plc
417.00
+0.36%
TLX.AX Telix Pharmaceuticals Limited
22.99
+0.57%
CRNX Crinetics Pharmaceuticals, Inc.
59.81
+1.10%
AUTL Autolus Therapeutics plc
4.0400
+13.17%
VERU Veru Inc.
0.7335
-1.32%
APLT Applied Therapeutics, Inc.
9.74
+0.93%